Grady Grant III serves as Executive at Aptevo Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Grady Grant III has executed 7 insider transactions totaling $28.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 10, 2025 involved purchasing 13,513 shares valued at $20.1K.
Grady Grant III currently holds 13,514 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Grady Grant III has been a net buyer of APVO stock. They have purchased $28.1K and sold $0 worth of shares.
Grady Grant III's most recent insider trade was on Nov 10, 2025, when they purchased 13,513 shares at $1.49 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 1, 2024 | APVO | $0 | Option Exercise | 7 | $N/A | Discretionary |
| Aug 9, 2023 | APVO | $0 | Option Exercise | 3,571 | $N/A | Discretionary |
| Jun 1, 2023 | APVO | $0 | Option Exercise | 297 | $N/A | Discretionary |
| Jun 1, 2022 | APVO | $0 | Option Exercise | 298 | $N/A | Discretionary |
| May 21, 2019 | APVO | $8.0K | Purchase | 10,000 | $0.80 | Discretionary |